NCT02767700View on ClinicalTrials.gov

NGS and TME for Evidence-based Treatment of Pancreatic Cancer

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

March 25, 2018

Study Completion Date

August 31, 2018

Conditions
Pancreatic Ductal Adenocarcinoma
Interventions
GENETIC

NGS

Next generation sequencing

All Listed Sponsors
lead

Karolinska University Hospital

OTHER

NCT02767700 - NGS and TME for Evidence-based Treatment of Pancreatic Cancer | Biotech Hunter | Biotech Hunter